4.5 Article

Increased Risk of Ischemic Stroke in Systemic Sclerosis: A National Cohort Study of US Veterans

Journal

JOURNAL OF RHEUMATOLOGY
Volume 47, Issue 1, Pages 82-88

Publisher

J RHEUMATOL PUBL CO
DOI: 10.3899/jrheum.181311

Keywords

SYSTEMIC SCLEROSIS; STROKE; VETERANS HEALTH; PROPORTIONAL HAZARDS MODELS; MATCHED-PAIR ANALYSIS

Categories

Funding

  1. US Department of Veterans Affairs Merit Review grant
  2. National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIH/NIAMS) [K23 AR063770]
  3. National Center for Advancing Translational Sciences, NIH, through the University of California, San Francisco Clinical and Translational Science Institute (UCSF-CTSI) [UL1 TR001872]
  4. Rosalind Russell/Ephraim Engleman Rheumatology Research Center
  5. NIH/NIAMS [P30 AR070155]

Ask authors/readers for more resources

Objective. Previously thought to involve primarily the microvasculature, systemic sclerosis (SSc) has been increasingly linked to macrovascular disease. Cardiovascular (CV) and cerebrovascular disease are responsible for 20-30% of mortality in SSc, but few studies have shown an independent association between SSc and stroke. We assessed whether SSc was an independent risk factor for ischemic stroke. Methods. We conducted a retrospective cohort study using the national Veterans Affairs (VA) administrative database containing records from 1999 to 2014. We obtained data for all patients with a diagnosis of SSc as well as 2 controls per SSc patient matched on sex, race, smoking status, and VA site. All patients were followed until development of ischemic stroke, death, or last encounter. We used a Cox proportional hazard regression model to estimate risk of ischemic stroke, with adjustments for CV comorbidities (hypertension, diabetes, atrial fibrillation, non-cerebrovascular atherosclerotic disease, hyperlipidemia), baseline medication use (aspirin, nonsteroidal antiinflammatory drugs), and Medicare enrollment. Results. Among 4545 individuals with SSc (83% male, mean age 60.9 yrs), the incidence rate of ischemic stroke was 15.3 per 1000 person-years (vs 12.2 in the control cohort), with an unadjusted HR 1.28 (95% CI 1.11-1.47). The adjusted HR was 1.21 (95% CI 1.05-1.40) after adjusting for baseline CV risk factors, medications, and Medicare enrollment. Conclusion. SSc is independently associated with a higher risk of ischemic stroke among US veterans. Patients with SSc represent a population likely to benefit from targeted stroke screening or prevention therapies.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Rheumatology

High Disease Severity Among Asian Patients in a US Multiethnic Cohort of Individuals With Systemic Lupus Erythematosus

Kimberly DeQuattro, Laura Trupin, Louise B. Murphy, Stephanie Rush, Lindsey A. Criswell, Cristina M. Lanata, Maria Dall'Era, Patricia Katz, Jinoos Yazdany

Summary: This study found that systemic lupus erythematosus (SLE) is more severe among US Asian patients compared to White patients. Filipinos are affected at a younger age. Asian patients and non-White groups with younger age at diagnosis have greater organ damage than White patients.

ARTHRITIS CARE & RESEARCH (2022)

Article Rheumatology

Development of a Natural Language Processing System for Extracting Rheumatoid Arthritis Outcomes From Clinical Notes Using the National Rheumatology Informatics System for Effectiveness Registry

Marie Humbert-Droz, Zara Izadi, Gabriela Schmajuk, Milena Gianfrancesco, Matthew C. Baker, Jinoos Yazdany, Suzanne Tamang

Summary: We developed and evaluated a natural language processing (NLP) pipeline to extract outcome measures from rheumatology notes, and found it to have good internal and external validity.

ARTHRITIS CARE & RESEARCH (2023)

Article Rheumatology

Predictors of Thirty-Day Hospital Readmissions in Systemic Lupus Erythematosus in the United States: A Nationwide Study

Rayan Najjar, Swetha A. A. Alexander, Grant C. C. Hughes, Jinoos Yazdany, Namrata Singh

Summary: This study evaluated independent risk factors for readmission in patients with systemic lupus erythematosus (SLE) and identified the major reasons for readmission. The results showed that younger age, SLE-related manifestations, and public insurance were the strongest risk factors for 30-day readmission. These findings can help improve health outcomes for SLE patients through targeted interventions.

ARTHRITIS CARE & RESEARCH (2023)

Article Rheumatology

Race, Ethnicity, and Disparities in the Risk of End-Organ Lupus Manifestations Following a Systemic Lupus Erythematosus Diagnosis in a Multiethnic Cohort

Alfredo Aguirre, Zara Izadi, Laura Trupin, Kamil E. Barbour, Kurt J. Greenlund, Patti Katz, Cristina Lanata, Lindsey Criswell, Maria Dall'Era, Jinoos Yazdany

Summary: This study analyzed racial and ethnic differences in the risk of end-organ lupus manifestations following SLE diagnosis. The results showed that Hispanic and Asian patients with SLE had heightened risks of developing renal, hematologic, and multiorgan disease.

ARTHRITIS CARE & RESEARCH (2023)

Article Rheumatology

Does Higher Quality of Care in Systemic Lupus Erythematosus Improve Quality of Life?

Shilpa Arora, Patricia Katz, Ailda Nika, Winston Sequeira, Joel A. A. Block, Jinoos Yazdany, Ed Yelin, Meenakshi Jolly

Summary: This study aimed to examine the association between high quality of care (QOC) and quality of life (QOL) and nonroutine health care use (HCU) in systemic lupus erythematosus. The study found that higher QOC was associated with worse scores on SF-36 domains at baseline, which was influenced by comorbidities and high disease activity. The results show that high QOC is not predictive of significant improvement in SF-36 scores and nonroutine HCU on follow-up.

ARTHRITIS CARE & RESEARCH (2023)

Article Rheumatology

Causes of Death Among Individuals With Systemic Lupus Erythematosus by Race and Ethnicity: A Population-Based Study

Tiffany Taylor, Christine Anastasiou, Clairissa Ja, Stephanie Rush, Laura Trupin, Maria Dall'Era, Patricia Katz, Kamil E. Barbour, Kurt J. Greenlund, Jinoos Yazdany, Milena A. Gianfrancesco

Summary: This study found that individuals with systemic lupus erythematosus (SLE) of non-White populations, particularly Asian and Hispanic individuals, have a higher risk of cardiovascular disease (CVD) mortality compared to the general population.

ARTHRITIS CARE & RESEARCH (2023)

Editorial Material Rheumatology

Cardiovascular Disease Disparities in Systemic Lupus Erythematosus

Ali Duarte-Garcia, Jinoos Yazdany

JOURNAL OF RHEUMATOLOGY (2023)

Article Rheumatology

Monitoring and Achievement of Target Serum Urate Among Gout Patients Receiving Long-Term Urate-Lowering Therapy in the American College of Rheumatology RISE Registry

Nevin Hammam, Jing Li, Julia Kay, Zara Izadi, Jinoos Yazdany, Gabriela Schmajuk

Summary: The American College of Rheumatology's (ACR) 2020 guidelines recommend a treat-to-target approach for gout management. A study using the ACR registry found that more than half of gout patients receiving long-term urate-lowering therapy (ULT) had documented serum urate (SU) levels, and among those tested, three-quarters achieved the recommended SU target. Non-White patients were slightly less likely to be tested or achieve the target SU level.

ARTHRITIS CARE & RESEARCH (2023)

Article Rheumatology

The association of trauma with self-reported flares and disease activity in systemic lupus erythematosus (SLE)

Patricia Katz, Sarah L. Patterson, Kimberly DeQuattro, Cristina M. Lanata, Kamil E. Barbour, Kurt J. Greenlund, Caroline Gordon, Lindsey A. Criswell, Maria Dall'Era, Jinoos Yazdany

Summary: This study examines the association between trauma exposure and patient-reported SLE disease activity and flares. It found that any traumatic event increases the odds of a flare and is associated with higher disease activity scores. Patients with a history of trauma reported more flares and greater disease activity. Therefore, understanding the mechanisms behind the association between trauma and disease activity and implementing interventions to mitigate the effects of trauma exposures is crucial.

RHEUMATOLOGY (2023)

Article Rheumatology

Perceived Stress and Prediction of Worse Disease Activity and Symptoms in a Multiracial, Multiethnic Systemic Lupus Erythematosus Cohort

Sarah Patterson, Laura Trupin, Wendy Hartogensis, Kimberly DeQuattro, Cristina Lanata, Caroline Gordon, Kamil E. E. Barbour, Kurt J. J. Greenlund, Maria Dall'Era, Jinoos Yazdany, Patricia Katz

Summary: Several studies have shown a potential link between traumatic experiences, psychological stress, and autoimmunity. However, the impact of stress on disease activity and symptom severity in systemic lupus erythematosus (SLE) has not been fully understood. This study aimed to examine whether increases in perceived stress independently associate with worse SLE disease outcomes over a 3-year follow-up period. The results suggest that an increase in stress is associated with greater disease activity and symptom burden in individuals with SLE.

ARTHRITIS CARE & RESEARCH (2023)

Article Medical Informatics

Practical Considerations for Developing Clinical Natural Language Processing Systems for Population Health Management and Measurement

Suzanne Tamang, Marie Humbert-Droz, Milena Gianfrancesco, Zara Izadi, Gabriela Schmajuk, Jinoos Yazdany

Summary: Experts highlight the gap between clinical NLP research and real-world applications, offering practical considerations for developing NLP systems that can support clinical needs and improve health outcomes. These considerations involve assessing data and compute resources readiness, organizational incentives, and feasibility of implementation. They are beneficial for the design of future clinical NLP projects in various settings, including large health systems and clinical practices with electronic medical records.

JMIR MEDICAL INFORMATICS (2023)

Article Endocrinology & Metabolism

Spectrum of Clinical Presentations, Imaging Findings, and HLA Types in Immune Checkpoint Inhibitor-Induced Hypophysitis

Zoe Quandt, Stephanie Kim, Javier Villanueva-Meyer, Catherine Coupe, Arabella Young, Jee Hye Kang, Jinoos Yazdany, Gabriela Schmajuk, Stephanie Rush, Elad Ziv, Ana Luisa Perdigoto, Kevan Herold, Melissa G. Lechner, Maureen A. Su, J. Blake Tyrrell, Jeffrey Bluestone, Mark Anderson, Umesh Masharani

Summary: This study investigated the clinical, imaging, and HLA characteristics of CPI-induced hypophysitis. It found that exposure to CTLA-4 inhibitors resulted in a faster onset of hypophysitis compared to PD-1/PD-L1 inhibitor monotherapy, and abnormalities were observed on MRI. Male patients were more prone to develop hypophysitis, and the HLA DQ0602 gene may be related to its development.

JOURNAL OF THE ENDOCRINE SOCIETY (2023)

Review Rheumatology

Global Perspective on the Impact of the COVID-19 Pandemic on Rheumatology and Health Equity

Evelyn Hsieh, Dzifa Dey, Rebecca Grainger, Mengtao Li, Pedro M. Machado, Manuel F. Ugarte-Gil, Jinoos Yazdany

Summary: Although the public health emergency associated with the COVID-19 pandemic has ended, challenges remain for individuals with rheumatic diseases. Disruptions in healthcare and medication supply shortages have impacted the health and mental well-being of these individuals. Telemedicine and changes in healthcare utilization have also affected rheumatology practices globally. Efforts are needed to improve healthcare access, stabilize rheumatology drug supplies, and implement evidence-based vaccination practices to reduce COVID-19 morbidity and mortality among individuals with rheumatic diseases.

ARTHRITIS CARE & RESEARCH (2023)

Article Rheumatology

Risks of mortality and severe coronavirus disease 19 (COVID-19) outcomes in patients with or without systemic lupus erythematosus

Sebastian Bruera, Xiudong Lei, Hui Zhao, Jinoos Yazdany, Mariana Chavez-MacGregor, Sharon H. Giordano, Maria E. Suarez-Almazor

Summary: This study compared the outcomes of patients with or without systemic lupus erythematosus (SLE) who were diagnosed with COVID-19 and evaluated factors associated with severe outcomes in SLE patients. The results showed that patients with SLE had significantly higher rates of mortality, mechanical ventilation, and hospitalization compared to matched controls. Severe disease activity in SLE and prior use of corticosteroids were associated with worse outcomes.

LUPUS SCIENCE & MEDICINE (2023)

Article Rheumatology

Incidence Rate and Factors Associated With Fractures Among Medicare Beneficiaries With Ankylosing Spondylitis in the United States

Rachael Stovall, Emma Kersey, Jing Li, Rahaf Baker, Christine Anastasiou, Andriko Palmowski, Gabriela Schmajuk, Lianne Gensler, Jinoos Yazdany

Summary: The study found that in adults with ankylosing spondylitis, older age, previous fractures, and opioid use were associated with a higher risk of fractures. Men and women had similar fracture rates. Due to the association between opioid use and fractures in AS patients, interventions to reduce the risk should be considered.

ARTHRITIS CARE & RESEARCH (2023)

No Data Available